Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin D and Reduced Parathyroid Hormone Level

Research synthesisModerate evidenceSmall effect4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies, 3 report beneficial effects of vitamin D supplementation on reducing parathyroid hormone (PTH) levels, with small-to-moderate effect sizes (e.g., MD -4.19 pg/mL, SMD -0.49). Evidence primarily comes from systematic reviews and meta-analyses in clinical populations (depression patients, kidney transplant recipients, healthy adults). A neutral study in bariatric surgery patients found no significant difference between high and moderate doses. The median study duration was 90 days, suggesting effects may require several weeks to emerge.

  • Effective dose range: up to 5,000 IU/day
  • Studied populations: clinical populations (depression patients, kidney transplant recipients, healthy adults)

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). One study in bariatric surgery patients found no significant effect, suggesting benefits may vary by population.

Generated Jul 12, 2026
Doses used in studies
  • IU/day: 5,000–7,943 (median 5,735.75, IQR 5,0007,207.25) 2 studies
Time to effect
Median: 3 months · IQR 3 months3 months · Range 3 months3 months — Reported in 1 of 4 studies
Safety in these studies
4 of 4 papers
Back to top